These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1354032)

  • 21. Stimulations but not neuroleptics.
    Fujii M; Sasaki H
    Geriatr Gerontol Int; 2009 Sep; 9(3):217-9. PubMed ID: 19702930
    [No Abstract]   [Full Text] [Related]  

  • 22. [Neuroleptics and extrapyramidal effects from the biochemical viewpoint. Discussion by the Workshop on Neuroleptics and the Extrapyramidal System].
    Seyfried C
    Arzneimittelforschung; 1978; 28(9):1537-8. PubMed ID: 38815
    [No Abstract]   [Full Text] [Related]  

  • 23. Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality.
    Möller HJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1101-11. PubMed ID: 14642970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Possible participation of limbic structures of the forebrain in the mechanism of the antipsychotic effect of neuroleptic preparations in schizophrenia (review)].
    Aksent'ev SB; Mokhovikov AN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(8):1254-60. PubMed ID: 6137921
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparing sertindole to other new generation antipsychotics on preferential dopamine output in limbic versus striatal projection regions: mechanism of action.
    Hertel P
    Synapse; 2006 Dec; 60(7):543-52. PubMed ID: 16952163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs.
    Baldessarini RJ; Tarsy D
    Annu Rev Neurosci; 1980; 3():23-41. PubMed ID: 6106450
    [No Abstract]   [Full Text] [Related]  

  • 27. Limbic selectivity of clozapine.
    Pilowsky LS; Mulligan RS; Acton PD; Ell PJ; Costa DC; Kerwin RW
    Lancet; 1997 Aug; 350(9076):490-1. PubMed ID: 9274589
    [No Abstract]   [Full Text] [Related]  

  • 28. The relative role of dopamine and norepinephrine receptor blockade in the action of antipsychotic drugs: metoclopramide, thiethylperazine, and molindone as pharmacological tools.
    Robinson SE; Berney S; Mishra R; Sulser F
    Psychopharmacology (Berl); 1979 Aug; 64(2):141-7. PubMed ID: 40288
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute and chronic treatment with neuroleptics: similarities and differences in their action on nigrostriatal, mesolimbic, and mesocortical dopaminergic neurons.
    Julou L; Scatton B; Glowinski J
    Adv Biochem Psychopharmacol; 1977; 16():617-24. PubMed ID: 18904
    [No Abstract]   [Full Text] [Related]  

  • 30. Tachykinin gene expression in rat limbic nuclei: modulation by dopamine antagonists.
    Shibata K; Haverstick DM; Bannon MJ
    J Pharmacol Exp Ther; 1990 Oct; 255(1):388-92. PubMed ID: 1976801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.
    Bressan RA; Erlandsson K; Jones HM; Mulligan R; Flanagan RJ; Ell PJ; Pilowsky LS
    Am J Psychiatry; 2003 Aug; 160(8):1413-20. PubMed ID: 12900302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amperozide--a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour.
    Gustafsson B; Christensson E
    Pharmacol Toxicol; 1990; 66 Suppl 1():12-7. PubMed ID: 1968250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective affinities of bromocriptine and lergotrile for rat limbic dopamine binding sites [proceedings].
    Blackburn KJ; Bremner RM; Greengrass PM; Morville M; Davey MJ
    Br J Pharmacol; 1978 Nov; 64(3):413P. PubMed ID: 31219
    [No Abstract]   [Full Text] [Related]  

  • 34. Repeated administration of (-)sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions.
    Memo M; Pizzi M; Nisoli E; Missale C; Carruba MO; Spano P
    Eur J Pharmacol; 1987 Jun; 138(1):45-51. PubMed ID: 2887436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroanatomical, neuropharmacological and neurobiochemical target systems for antipsychotic activity of neuroleptics.
    Delini-Stula A
    Pharmacopsychiatry; 1986 Jul; 19(4):134-9. PubMed ID: 2876445
    [No Abstract]   [Full Text] [Related]  

  • 37. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
    Hornykiewicz O
    Neuroscience; 1978; 3(9):773-83. PubMed ID: 30919
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dopaminergic receptors, multiple targets for neuroleptics].
    Martres MP; Sokoloff P; Giros B; Bouthenet ML; Pilon C; Lannfelt L; Schwartz JC
    Ann Med Psychol (Paris); 1992; 150(2-3):119-23. PubMed ID: 1364189
    [No Abstract]   [Full Text] [Related]  

  • 39. [The pharmacologist facing the neuroleptics].
    Costentin J
    Encephale; 1991 Jun; 17 Spec No 2():153-7. PubMed ID: 1677889
    [No Abstract]   [Full Text] [Related]  

  • 40. [Neuroleptics or antipsychotic agents].
    Dresse A
    Rev Med Liege; 1996 Jan; 51(1):65-9. PubMed ID: 8701140
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.